Omnio (Drug Discovery) Overview

  • Founded
  • 2006

Founded
  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $618K

  • Investors
  • 1

Omnio (Drug Discovery) General Information

Description

Developer of therapies for wound healing and anti-infection management. The company develops recombinant human plasminogen that helps in wound healing and offers its product in the form of ear drops for tympanic membrane perforation, enabling people to get rid of irritations.

Contact Information

Website
www.omnio.se
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
  • Uminova Science Park
  • Tvistevägen 48
  • 907 19 Umea
  • Sweden
+46 073-620 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omnio (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 06-Dec-2021 $618K 00.000 Completed Generating Revenue
2. Angel (individual) 00.000 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Omnio (Drug Discovery)’s complete valuation and funding history, request access »

Omnio (Drug Discovery) Patents

Omnio (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180326023-A1 Plasminogen dosage regimen for wound healing Abandoned 10-Nov-2015 0000000000 0
JP-2018534306-A Plasminogen administration plan for wound healing Pending 10-Nov-2015 0000000000
EP-3373957-A1 Plasminogen dosage regimen for wound healing Withdrawn 10-Nov-2015 0000000000
AU-2016352183-A1 Plasminogen dosage regimen for wound healing Abandoned 10-Nov-2015 0000000000
CA-3004509-A1 Plasminogen dosage regimen for wound healing Pending 10-Nov-2015 A61K38/484
To view Omnio (Drug Discovery)’s complete patent history, request access »

Omnio (Drug Discovery) Executive Team (4)

Name Title Board Seat Contact Info
Ulrika Norin Ph.D Chief Executive Officer
Sten Hellström Ph.D Co-Founder & Scientific Advisor
Jinan Li Ph.D Co-Founder
Tor Ny Ph.D Co-Founder, Head of Research & Development & Board Member
To view Omnio (Drug Discovery)’s complete executive team members history, request access »

Omnio (Drug Discovery) Board Members (4)

Name Representing Role Since
Lars Johansson Omnio (Drug Discovery) Chairman of the Board 000 0000
Lars Ohman Self Board Member 000 0000
Stefan Nilsson Self Board Member 000 0000
Tor Ny Ph.D Omnio (Drug Discovery) Co-Founder, Head of Research & Development & Board Member 000 0000
To view Omnio (Drug Discovery)’s complete board members history, request access »

Omnio (Drug Discovery) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Umeå Biotech Incubator Accelerator/Incubator 000 0000 000000 0
To view Omnio (Drug Discovery)’s complete investors history, request access »